The University of Chicago Header Logo

Omer Raheem

Concepts (379)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Erectile Dysfunction
12
2024
74
8.090
Why?
Penile Implantation
8
2023
13
5.930
Why?
Penile Prosthesis
9
2023
23
5.700
Why?
Hypogonadism
6
2022
37
3.980
Why?
Penis
7
2023
57
2.260
Why?
Prostatic Hyperplasia
4
2023
88
2.090
Why?
Urologic Diseases
3
2023
45
2.060
Why?
Infertility, Male
3
2023
24
1.810
Why?
Testosterone
5
2022
271
1.780
Why?
Male
73
2024
40988
1.730
Why?
Penile Induration
2
2023
6
1.730
Why?
Penile Diseases
3
2022
7
1.580
Why?
Quality of Life
7
2023
1585
1.470
Why?
Cardiovascular Diseases
3
2022
827
1.280
Why?
Humans
83
2024
86678
1.260
Why?
Lower Urinary Tract Symptoms
2
2021
59
1.240
Why?
Prostatectomy
8
2022
471
1.230
Why?
Organ Transplantation
2
2021
265
1.200
Why?
Urolithiasis
2
2017
4
1.140
Why?
Prostatic Neoplasms
7
2021
1721
1.090
Why?
Carcinoma, Renal Cell
9
2019
426
1.080
Why?
Kidney Neoplasms
10
2019
621
1.070
Why?
Nephrectomy
12
2019
294
1.060
Why?
Sexual Dysfunction, Physiological
2
2022
67
1.020
Why?
Urinary Bladder
3
2017
246
0.980
Why?
Penile Neoplasms
1
2023
10
0.940
Why?
Semen
1
2023
13
0.940
Why?
Vasectomy
1
2023
4
0.930
Why?
Urinary Sphincter, Artificial
2
2020
13
0.920
Why?
Exosomes
1
2023
50
0.900
Why?
Hyaluronic Acid
1
2022
49
0.860
Why?
Penile Erection
4
2023
22
0.860
Why?
Telemedicine
2
2024
169
0.840
Why?
Transurethral Resection of Prostate
1
2021
9
0.820
Why?
Premature Ejaculation
1
2021
1
0.810
Why?
Urinary Bladder Neoplasms
3
2020
383
0.790
Why?
Genitalia
1
2021
21
0.780
Why?
Urinary Incontinence, Stress
2
2020
192
0.780
Why?
Hyperthyroidism
1
2021
75
0.780
Why?
Mycophenolic Acid
2
2011
87
0.770
Why?
Postoperative Complications
9
2020
2207
0.770
Why?
Transgender Persons
1
2022
95
0.770
Why?
Vaping
1
2021
29
0.760
Why?
Urinary Tract
1
2021
34
0.760
Why?
Extracorporeal Shockwave Therapy
1
2020
2
0.760
Why?
Electronic Nicotine Delivery Systems
1
2021
50
0.740
Why?
Urinary Incontinence
1
2022
206
0.730
Why?
Thrombosis
2
2021
296
0.720
Why?
Urinary Bladder, Neurogenic
1
2020
25
0.720
Why?
Sexual and Gender Minorities
1
2023
192
0.700
Why?
Self-Injurious Behavior
1
2021
105
0.660
Why?
Retrospective Studies
22
2022
8496
0.650
Why?
Cystocele
1
2016
7
0.590
Why?
Middle Aged
29
2023
25040
0.580
Why?
Immunosuppressive Agents
2
2013
977
0.570
Why?
Kidney Transplantation
3
2013
849
0.560
Why?
Allografts
1
2016
172
0.550
Why?
Skin Transplantation
1
2016
172
0.540
Why?
Aged
25
2023
18423
0.540
Why?
Female
32
2023
44550
0.530
Why?
Vagina
1
2016
161
0.530
Why?
Music Therapy
1
2015
3
0.530
Why?
Treatment Outcome
14
2021
7998
0.520
Why?
Cystoscopy
1
2015
35
0.520
Why?
Health Care Costs
1
2017
239
0.510
Why?
Edema
1
2014
71
0.500
Why?
Ambulatory Surgical Procedures
1
2015
74
0.490
Why?
Adenocarcinoma, Mucinous
1
2014
48
0.490
Why?
Chronic Pain
1
2016
145
0.480
Why?
Urology
4
2020
110
0.470
Why?
Drainage
1
2014
157
0.470
Why?
Prospective Studies
6
2023
4214
0.460
Why?
Bone Neoplasms
2
2014
322
0.460
Why?
Robotic Surgical Procedures
4
2020
267
0.460
Why?
Fertility
2
2023
115
0.450
Why?
Kidney
3
2019
1242
0.450
Why?
Anxiety
1
2015
287
0.440
Why?
Arthritis, Reactive
1
2012
2
0.440
Why?
Analgesics, Opioid
2
2016
413
0.440
Why?
Hepatitis B, Chronic
1
2013
32
0.440
Why?
Renal Veins
2
2013
28
0.430
Why?
Urography
1
2012
45
0.430
Why?
Obesity
3
2020
964
0.430
Why?
Pain
1
2015
391
0.430
Why?
BCG Vaccine
1
2012
31
0.430
Why?
Hematuria
1
2012
49
0.420
Why?
Prevalence
4
2021
1239
0.420
Why?
Nephrolithiasis
1
2012
22
0.420
Why?
Osteolysis
1
2011
14
0.410
Why?
Guanine
1
2013
208
0.410
Why?
Antiretroviral Therapy, Highly Active
1
2012
64
0.410
Why?
Femoral Neoplasms
1
2011
24
0.410
Why?
Lateral Ligament, Ankle
1
2011
1
0.400
Why?
Urinary Catheterization
1
2011
35
0.400
Why?
Adjuvants, Immunologic
1
2012
167
0.400
Why?
Osteoblasts
1
2011
95
0.400
Why?
Motor Activity
1
2014
327
0.400
Why?
Ankle
1
2011
20
0.400
Why?
Laparoscopy
5
2019
754
0.400
Why?
Hormone Replacement Therapy
2
2022
77
0.390
Why?
HIV Infections
3
2017
772
0.390
Why?
Transplantation Immunology
1
2011
84
0.390
Why?
Femur
1
2011
116
0.390
Why?
Carcinoma, Transitional Cell
1
2012
164
0.380
Why?
Length of Stay
6
2020
704
0.380
Why?
Azathioprine
1
2011
125
0.380
Why?
Graft Survival
2
2011
885
0.380
Why?
Diet
1
2014
443
0.380
Why?
Urinary Fistula
1
2009
7
0.370
Why?
Xenograft Model Antitumor Assays
1
2011
458
0.360
Why?
Rectal Fistula
1
2009
18
0.360
Why?
Prosthesis-Related Infections
2
2020
58
0.350
Why?
Cadaver
5
2012
185
0.340
Why?
Adult
18
2023
25659
0.340
Why?
Urethra
2
2020
113
0.340
Why?
Tomography, X-Ray Computed
4
2019
2601
0.340
Why?
Antiviral Agents
1
2013
512
0.330
Why?
Androgen Antagonists
3
2021
144
0.300
Why?
Men's Health
2
2024
6
0.290
Why?
Renal Artery
1
2007
64
0.290
Why?
Ureteroscopy
2
2017
37
0.280
Why?
Lithotripsy
2
2017
41
0.280
Why?
Wounds and Injuries
1
2009
231
0.280
Why?
United States
5
2023
6681
0.280
Why?
Kidney Failure, Chronic
1
2011
509
0.280
Why?
Surveys and Questionnaires
3
2022
2504
0.270
Why?
Cohort Studies
6
2020
2768
0.270
Why?
Knee Joint
1
2007
168
0.270
Why?
Follow-Up Studies
6
2016
3642
0.260
Why?
Pain Measurement
2
2016
321
0.240
Why?
Adolescent
6
2023
8984
0.240
Why?
Spermatogonia
1
2023
13
0.240
Why?
Risk Factors
8
2020
5420
0.240
Why?
Reproductive Techniques, Assisted
1
2023
15
0.230
Why?
California
2
2015
138
0.230
Why?
Maternal Age
1
2023
44
0.230
Why?
Demography
2
2015
177
0.230
Why?
Robotics
2
2019
267
0.230
Why?
Gels
1
2022
48
0.220
Why?
Longitudinal Studies
4
2020
1019
0.220
Why?
Aged, 80 and over
5
2015
6513
0.220
Why?
Carcinoma, Squamous Cell
1
2009
1077
0.220
Why?
Personal Satisfaction
1
2023
62
0.220
Why?
Gender Identity
1
2022
52
0.210
Why?
Insurance, Health
1
2023
160
0.210
Why?
Natural Orifice Endoscopic Surgery
2
2012
38
0.210
Why?
Syndrome
1
2022
446
0.200
Why?
North America
2
2024
180
0.200
Why?
Ejaculation
1
2021
9
0.200
Why?
Kidney Calculi
2
2015
339
0.200
Why?
Drug Therapy, Combination
1
2023
895
0.200
Why?
Endoscopy
2
2017
332
0.200
Why?
Aromatase Inhibitors
1
2021
28
0.200
Why?
Selective Estrogen Receptor Modulators
1
2021
34
0.200
Why?
Prostate-Specific Antigen
2
2015
353
0.200
Why?
Sexual Dysfunctions, Psychological
1
2021
32
0.190
Why?
Ireland
2
2011
9
0.190
Why?
Fibrosis
1
2021
203
0.190
Why?
Patient Discharge
2
2020
300
0.190
Why?
Urethral Stricture
1
2020
13
0.180
Why?
Urinary Retention
1
2020
40
0.180
Why?
Conservative Treatment
1
2019
20
0.180
Why?
Dissection
2
2011
42
0.180
Why?
Medicare
1
2023
410
0.180
Why?
Abdominal Injuries
1
2019
39
0.180
Why?
Patient Satisfaction
1
2023
455
0.170
Why?
Neoplasm Recurrence, Local
2
2016
1313
0.170
Why?
Urologic Surgical Procedures, Male
2
2020
11
0.170
Why?
Prosthesis Failure
1
2020
111
0.170
Why?
Genitalia, Male
1
2019
24
0.170
Why?
Ultrasonography
1
2021
695
0.170
Why?
Wounds, Nonpenetrating
1
2019
92
0.170
Why?
Priapism
1
2018
5
0.170
Why?
Cannabis
1
2019
34
0.160
Why?
Prosthesis Implantation
1
2020
125
0.160
Why?
Mortality
1
2019
149
0.160
Why?
Disease-Free Survival
3
2016
1204
0.160
Why?
Urologic Neoplasms
1
2019
77
0.160
Why?
Surgical Wound Infection
1
2020
184
0.160
Why?
Nephrolithotomy, Percutaneous
1
2017
8
0.150
Why?
Operative Time
4
2020
127
0.150
Why?
Neoplasm Staging
2
2015
1939
0.150
Why?
Pilot Projects
2
2018
840
0.150
Why?
Specialization
1
2017
65
0.150
Why?
Empyema
1
2017
9
0.150
Why?
Neoplasm Grading
2
2016
357
0.150
Why?
Disease Management
1
2019
327
0.150
Why?
Asia
1
2017
95
0.150
Why?
Australia
1
2017
99
0.150
Why?
Animals
5
2023
26590
0.150
Why?
Urinary Bladder Diseases
1
2017
41
0.150
Why?
Solvents
1
2016
96
0.140
Why?
Ischemia
1
2018
243
0.140
Why?
Europe
1
2017
309
0.140
Why?
Cryosurgery
1
2016
41
0.140
Why?
Kaplan-Meier Estimate
2
2016
861
0.140
Why?
Mice
3
2023
11356
0.140
Why?
Risk Assessment
2
2016
2264
0.140
Why?
Endocrinology
1
2017
66
0.140
Why?
Postoperative Hemorrhage
1
2016
46
0.140
Why?
Guideline Adherence
1
2017
224
0.140
Why?
Databases, Factual
2
2019
816
0.130
Why?
Young Adult
3
2023
5980
0.130
Why?
Age Factors
3
2016
1852
0.130
Why?
Multivariate Analysis
2
2015
1001
0.130
Why?
Morbidity
3
2020
148
0.130
Why?
Platelet Aggregation Inhibitors
1
2016
134
0.130
Why?
Graft Rejection
2
2011
1065
0.130
Why?
Bacteriuria
1
2014
10
0.130
Why?
Leiomyosarcoma
1
2015
40
0.130
Why?
Epstein-Barr Virus Infections
1
2015
50
0.130
Why?
Nephrostomy, Percutaneous
1
2014
31
0.130
Why?
Patient Protection and Affordable Care Act
1
2015
66
0.130
Why?
Family Health
1
2015
162
0.130
Why?
Guidelines as Topic
1
2016
162
0.130
Why?
Escherichia coli Infections
1
2014
35
0.130
Why?
Systemic Inflammatory Response Syndrome
1
2014
49
0.120
Why?
Insurance Coverage
1
2015
117
0.120
Why?
Logistic Models
2
2015
1188
0.120
Why?
Drug Resistance, Multiple, Bacterial
1
2014
44
0.120
Why?
Orchiectomy
1
2014
68
0.120
Why?
Testicular Neoplasms
1
2015
105
0.120
Why?
Veterans
1
2015
72
0.120
Why?
Primary Health Care
1
2017
339
0.120
Why?
5-alpha Reductase Inhibitors
1
2014
7
0.120
Why?
Recurrence
1
2017
1139
0.120
Why?
Membrane Proteins
2
2012
1196
0.120
Why?
Fever
1
2014
125
0.120
Why?
Rats
1
2020
3992
0.120
Why?
Regression Analysis
1
2015
596
0.120
Why?
Skin
1
2016
554
0.110
Why?
Lamivudine
1
2013
13
0.110
Why?
Psychiatric Status Rating Scales
1
2015
487
0.110
Why?
Hepatitis B virus
1
2013
43
0.110
Why?
Proportional Hazards Models
1
2015
860
0.110
Why?
Medicaid
1
2015
217
0.110
Why?
Pelvis
1
2013
95
0.110
Why?
Virus Activation
1
2013
41
0.110
Why?
Cost-Benefit Analysis
1
2015
455
0.110
Why?
Radiography
1
2014
813
0.110
Why?
Practice Patterns, Physicians'
1
2017
584
0.110
Why?
Muscular Dystrophies, Limb-Girdle
1
2012
14
0.110
Why?
Chloride Channels
1
2012
42
0.100
Why?
Pyrroles
1
2013
184
0.100
Why?
Rupture
1
2011
63
0.100
Why?
Thrombectomy
1
2013
158
0.100
Why?
Cystostomy
1
2011
15
0.100
Why?
Vena Cava, Inferior
1
2013
143
0.100
Why?
Body Weights and Measures
1
2011
27
0.100
Why?
Peritoneum
1
2011
57
0.100
Why?
Lymph Node Excision
1
2013
217
0.100
Why?
X-Ray Microtomography
1
2011
80
0.100
Why?
Heart Atria
1
2013
250
0.100
Why?
Survival Rate
2
2015
1864
0.100
Why?
Mice, SCID
1
2011
252
0.100
Why?
Receptors, Androgen
1
2011
113
0.100
Why?
Sepsis
1
2014
306
0.100
Why?
Indoles
1
2013
318
0.100
Why?
Osteoporotic Fractures
1
2011
38
0.100
Why?
Neoplasm Invasiveness
1
2012
552
0.100
Why?
Urologic Surgical Procedures
1
2012
146
0.090
Why?
Heart Diseases
1
2013
290
0.090
Why?
Cyclosporine
1
2011
234
0.090
Why?
Child
3
2011
6928
0.090
Why?
Venous Thrombosis
1
2013
243
0.090
Why?
Postoperative Care
1
2011
221
0.090
Why?
Osteoporosis
1
2011
121
0.090
Why?
Trauma Severity Indices
2
2019
42
0.090
Why?
Plant Extracts
1
2011
244
0.090
Why?
Cell Line, Tumor
2
2012
2426
0.090
Why?
Ependymoma
1
2009
17
0.080
Why?
Spinal Neoplasms
1
2009
50
0.080
Why?
Epigenesis, Genetic
1
2012
481
0.080
Why?
DNA Methylation
1
2012
628
0.080
Why?
Cystectomy
2
2020
102
0.080
Why?
Disease Models, Animal
1
2014
2231
0.080
Why?
Tendon Injuries
1
2007
37
0.080
Why?
Infant
2
2011
3047
0.080
Why?
Ligaments, Articular
1
2007
36
0.070
Why?
Blood Transfusion
2
2019
157
0.070
Why?
Menisci, Tibial
1
2007
25
0.070
Why?
Tendons
1
2007
44
0.070
Why?
Child, Preschool
2
2011
3613
0.070
Why?
Gene Expression Profiling
1
2012
1384
0.070
Why?
Suture Techniques
1
2007
135
0.070
Why?
Gene Expression Regulation, Neoplastic
1
2011
1197
0.070
Why?
Severity of Illness Index
1
2011
1802
0.070
Why?
Diagnosis, Differential
1
2009
1566
0.070
Why?
Wound Healing
1
2007
344
0.070
Why?
Blood Loss, Surgical
2
2016
112
0.060
Why?
Patient Readmission
2
2019
329
0.060
Why?
Comorbidity
2
2019
944
0.060
Why?
Biomarkers, Tumor
1
2011
1464
0.060
Why?
Brain Neoplasms
1
2009
763
0.060
Why?
Antineoplastic Agents
1
2013
2360
0.050
Why?
Magnetic Resonance Imaging
2
2012
3362
0.050
Why?
Sexual Behavior
1
2024
302
0.050
Why?
Mutation
1
2012
3968
0.050
Why?
Pain, Postoperative
2
2013
240
0.050
Why?
Reproducibility of Results
2
2019
2706
0.040
Why?
Propensity Score
1
2019
136
0.040
Why?
Outpatients
1
2019
94
0.040
Why?
Trauma Centers
1
2019
116
0.040
Why?
Renal Insufficiency
1
2019
114
0.040
Why?
Patient Simulation
1
2018
42
0.040
Why?
Intraoperative Complications
1
2019
185
0.040
Why?
Minimally Invasive Surgical Procedures
1
2019
237
0.040
Why?
Anuria
1
2017
6
0.040
Why?
Therapeutic Irrigation
1
2017
60
0.040
Why?
Reoperation
1
2019
597
0.040
Why?
Urinary Diversion
1
2017
42
0.040
Why?
Coronary Thrombosis
1
2016
14
0.040
Why?
Perioperative Period
1
2016
25
0.040
Why?
Educational Measurement
1
2018
226
0.040
Why?
Inpatients
1
2019
298
0.030
Why?
Body Mass Index
1
2019
770
0.030
Why?
Survival Analysis
1
2019
1538
0.030
Why?
Quality Improvement
1
2019
429
0.030
Why?
Aspirin
1
2016
156
0.030
Why?
Tumor Burden
1
2016
289
0.030
Why?
SEER Program
1
2015
190
0.030
Why?
Tosyl Compounds
1
2014
15
0.030
Why?
Cost of Illness
1
2015
150
0.030
Why?
Anilides
1
2014
47
0.030
Why?
Heterografts
1
2014
98
0.030
Why?
Education, Medical, Graduate
1
2018
373
0.030
Why?
Nitriles
1
2014
149
0.030
Why?
Curriculum
1
2018
543
0.030
Why?
Lymphocele
1
2013
6
0.030
Why?
Neoplastic Cells, Circulating
1
2013
70
0.030
Why?
Biopsy
1
2016
1163
0.030
Why?
Anoctamins
1
2012
1
0.030
Why?
Finland
1
2012
29
0.030
Why?
Cardiopulmonary Bypass
1
2013
148
0.030
Why?
Creatine Kinase
1
2012
52
0.030
Why?
Genes, Recessive
1
2012
87
0.030
Why?
Serenoa
1
2011
1
0.030
Why?
Forecasting
1
2013
305
0.030
Why?
Disease Progression
1
2016
1532
0.030
Why?
Combined Modality Therapy
1
2015
1686
0.030
Why?
Anti-Bacterial Agents
1
2017
747
0.030
Why?
Muscle Weakness
1
2012
61
0.030
Why?
Rectum
1
2012
146
0.030
Why?
Acidosis
1
2011
55
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2012
273
0.030
Why?
Abdomen
1
2012
122
0.030
Why?
Protein-Tyrosine Kinases
1
2013
302
0.020
Why?
Age of Onset
1
2012
310
0.020
Why?
Lymphatic Metastasis
1
2013
486
0.020
Why?
Time Factors
1
2020
5214
0.020
Why?
Absorptiometry, Photon
1
2011
99
0.020
Why?
Terminology as Topic
1
2012
217
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2012
879
0.020
Why?
Feasibility Studies
1
2012
751
0.020
Why?
Blotting, Western
1
2012
782
0.020
Why?
Phytotherapy
1
2011
133
0.020
Why?
Lymph Nodes
1
2013
533
0.020
Why?
Promoter Regions, Genetic
1
2012
937
0.020
Why?
Patient Selection
1
2013
686
0.020
Why?
Muscle, Skeletal
1
2012
449
0.020
Why?
Tissue Array Analysis
1
2009
124
0.020
Why?
Protein Kinase Inhibitors
1
2013
589
0.020
Why?
World Health Organization
1
2009
103
0.020
Why?
Prognosis
1
2016
3680
0.020
Why?
Incidence
1
2013
1578
0.020
Why?
Cytoplasm
1
2009
281
0.020
Why?
Genetic Testing
1
2012
535
0.020
Why?
Tensile Strength
1
2007
79
0.020
Why?
Sutures
1
2007
52
0.020
Why?
Random Allocation
1
2007
332
0.020
Why?
Genotype
1
2012
1852
0.020
Why?
Cell Nucleus
1
2009
580
0.020
Why?
Membrane Glycoproteins
1
2009
428
0.020
Why?
Swine
1
2007
555
0.020
Why?
DNA
1
2012
1294
0.020
Why?
Phenotype
1
2012
2380
0.020
Why?
Genetic Variation
1
2012
1351
0.020
Why?
Immunohistochemistry
1
2009
1753
0.020
Why?
Gene Expression
1
2009
1284
0.020
Why?
Raheem's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (379)
Explore
_
Co-Authors (6)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_